Agomelatine

Chemical formula: C₁₅H₁₇NO₂  Molecular mass: 243.301 g/mol  PubChem compound: 82148

Therapeutic indications

Agomelatine is indicated for:

Major depressive episodes

Population group: only adults (18 years old or older)

Agomelatine is indicated for the treatment of major depressive episodes in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Agomelatine is contraindicated in the following cases:

Potent CYP1A2 inhibitors

Strong CYP1A2 inhibitors

Hepatic impairment

at least one of
Hepatic insufficiency
Alanine aminotransferase above reference range
Serum glutamic oxaloacetic transaminase level raised

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2025: VALDOXAN Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈